CTU at Shaikh Zayed Postgraduate Medical Institute is established in 2023 with following purpose;
- To conduct international, national and local clinical research studies including trials.
- To serve as a DRAP-approved site for all phases of drug trials.
- To collaborate with CROs (Contract Research Organizations), pharmaceutical companies and other research institutes from Pakistan and internationally.
- To run a dynamic CTU webpage on the SKZMDC/SZMC website so to improve the visibility of research activities and output.
- To provide technical and ethical guidance, facilitation, training, and resources to SZPGMI and SKZMDC investigators and researchers.
- To provide support for clinical research regulatory compliance, including registration with international registering bodies like ClinicalTrials.gov and Punjab Drug Regulatory Authority, DRAP, etc.
- To publish annual reports regularly in the form of a newsletter.
- To draft, modify, present, and get the approval of procedures for international drug trials/clinical trials by the Institutional Review and Research Advisory Board (IRRAB) that will serve as the advisory board/approval board for the CTU activities and annual report.